Latest publications for January from Cochrane Infectious Diseases Group

03 Feb 2021

Updated Cochrane Reviews

Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, Meremikwu MM, Critchley JA. Hand‐washing promotion for preventing diarrhoea. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No.: CD004265. DOI: 10.1002/14651858.CD004265.pub4.

Blanshard A, Hine P. Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD004529. DOI: 10.1002/14651858.CD004529.pub3.

Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD012768. DOI: 10.1002/14651858.CD012768.pub3.

 

The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise.
The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.